OphthalmologyNews.net

Ophthalmology Xagena

Xagena Mappa
Medical Meeting
Onco News
Mediexplorer.it

In the past decade, ophthalmologists have been prescribing nutritional supplements to be taken daily to prevent or slow vision loss from age-related macular degeneration ( AMD ). Now, using nutritiona ...


The clinical efficacy and toxicity of Amiodarone ( Cordarone ) may be determined more effectively by tissue deposition than by levels of the agent in serum. Therefore, corneal densitometry might be us ...


Primary open-angle glaucoma ( POAG ) is a blinding disease. Two important risk factors for this disease are a positive family history and elevated intraocular pressure ( IOP ), which is also highly he ...


Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibited promising activity in a proof-of-concept study when administered in intravenous ( IV ) doses to patients with active, chr ...


The purpose of a study was to evaluate the effect of monthly intravitreal Ranibizumab ( Lucentis ) on hard exudate ( HE ) area and the impact of hard exudate on visual acuity ( VA ) outcomes in diabet ...


A single-practice retrospective chart review has reported on long-term visual outcomes in patients receiving continuous fixed-interval dosing of anti-vascular endothelial growth factor ( VEGF ) treatm ...


Eylea ( Aflibercept ) injection has been recommended for approval by the European Committee for Medicinal Products for Human Use ( CHMP ) for the treatment of visual impairment due to macular edema s ...


The FDA ( Food and Drug Administration ) has accepted for priority review the supplemental biologics license application ( sBLA ) for Eylea ( Aflibercept ) injection for the treatment of diabetic reti ...


The clinical and demographic profile of uveitis-related ocular hypertension ( OHT ) was studied and risk factors predisposing to development of ocular hypertension in uveitis were evaluated. Two ...


The aim of a study was to assess the clinical response to Golimumab ( Simponi ) in patients with non-infectious uveitis from a single centre that had previously been treated with other anti-TNF-alpha ...


In September 2014, the FDA ( Food and Drug Administration ) granted Eylea ( Aflibercept ) injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic ...


A study has assessed the safety and efficacy of Tocilizumab ( Actemra; RoActemra ) in patients with severe and refractory non-infectious uveitis. Eight consecutive unselected patients with severe a ...


Long-term daily multivitamin supplement use may lower cataract risk in men, according to a study of nearly 15,000 male physicians published in Ophthalmology, the journal of the American Academy of Oph ...


A new study published in the Journal of the American Association for Pediatric Ophthalmology and Strabismus ( AAPOS ) suggests that the biologic agent Adalimumab ( Humira ) may be a viable treatment o ...


The aim of the GEFAL trial was to evaluate the relative efficacy and safety profile of Bevacizumab ( Avastin ) versus Ranibizumab ( Lucentis ) intravitreal injections for the treatment of neovascular ...